02:04:41 pm 09/20/2023
Elon Musk's neuroscience venture, Neuralink, announced on Tuesday that it has secured the green light from an independent ethics board to kick off its inaugural human trials focusing on patients with paralysis. The study aims to assist individuals suffering from cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS).
While Neuralink did not disclose the exact number of participants for the six-year-long study, the company revealed that a specialized robot would perform the surgical implantation of a brain-computer interface (BCI) into the brain area responsible for movemen Read More
While Neuralink did not disclose the exact number of participants for the six-year-long study, the company revealed that a specialized robot would perform the surgical implantation of a brain-computer interface (BCI) into the brain area responsible for movemen Read More